Resources


Go Back

Cardiovascular case study: Global Phase III Study – Heart Failure & Actigraphy

18 May 2017

After case studies about autoimmune & skin diseases, psoriasis and oncology, Kayentis releases its cardiovascular case study regarding heart failure and actigraphy. Kayentis offers combined eCOA / ePRO expertise in cardiovascular and medical device.

Global Phase III study – Cardiovascular & heart failure

  • 600 patients
  • 150 sites
  • 20 countries
  • 26 languages

Challenges of the cardiovascular case study

  • An eCOA partner that could deliver an ePRO solution combined with proven data management and actigraphy expertise.
  • On-site ePRO solution and data management of actigraphy data.
  • Short study set-up timelines and interaction with the sponsor and different CROs for study implementation.

Frédérique MARION, Kayentis Business Development Director – May, 18, 2017

To download this case study, please click here:

Kayentis ePRO cardiovascular case study

Agenda

  • 06 September
    ARENA, OCT New England, 2017 - Boston, MA - USA - Booth #47 Schedule a meeting with Kayentis  Kayentis_outsourcing_Boston
  • 10 October
    ARENA OCT Nordics, 2017 - Copenhagen, Denmark Schedule a meeting with Kayentis ARENA OCT Nordics, 2017 - Copenhagen, Denmark
  • 14 November
    DMB Annual Conference, Paris - FRANCE  Schedule a meeting with Kayentis Kayentis_Data_Management_Biomedical
  • 28 November
    PCT Amsterdam - 28 & 29 November 2017 - Booth #103 Schedule a meeting with Kayentis Kayentis_Partnership_Clinical_trials
  • Follow us

    Download our brochure